In UK and Ireland, SMA Patients Demand Reimbursement for Spinraza

A drug appraisal committee of Britain’s National Institute for Health and Care Excellence (NICE) met in Manchester, England, for the third and final time March 6 to decide whether to recommend Spinraza (nusinersen) for the treatment of spinal muscular atrophy (SMA). Several hundred demonstrators organized by the nonprofit group TreatSMA staged a protest on the steps of NICE’s … Continue reading In UK and Ireland, SMA Patients Demand Reimbursement for Spinraza